WELL Health Technologies 향후 성장

Future 기준 점검 4/6

WELL Health Technologies은 연간 수입과 매출이 각각 129.5%와 14.3% 증가할 것으로 예상되고 EPS는 연간 129.9%만큼 증가할 것으로 예상됩니다.

핵심 정보

129.5%

이익 성장률

129.87%

EPS 성장률

Healthcare 이익 성장	58.6%
매출 성장률	14.3%
향후 자기자본이익률	n/a
애널리스트 커버리지	Good
마지막 업데이트	05 Sep 2025

최근 향후 성장 업데이트

WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 16

Recent updates

WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 16

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Apr 23

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Apr 22

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Apr 01

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

Mar 29

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

Jan 19 Market consolidation and clinic efficiency initiatives could significantly enhance WELL Health's revenue growth and net margins.

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Dec 31

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

Nov 29

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Nov 11

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Sep 09

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Jul 05

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11

이익 및 매출 성장 예측

TSX:WELL - 애널리스트 향후 추정치 및 과거 재무 데이터 (CAD Millions)
날짜	매출	이익	자유현금흐름	영업현금흐름	평균 애널리스트 수
12/31/2027	1,689	90	94	189	4
12/31/2026	1,566	16	96	153	14
12/31/2025	1,421	-17	86	86	14
6/30/2025	1,120	-116	45	83	N/A
3/31/2025	990	-25	-1	29	N/A
12/31/2024	920	33	-17	10	N/A
9/30/2024	934	61	33	47	N/A
6/30/2024	887	135	-12	10	N/A
3/31/2024	830	25	32	50	N/A
12/31/2023	776	0	41	66	N/A
9/30/2023	701	-7	60	81	N/A
6/30/2023	643	-4	61	76	N/A
3/31/2023	612	-5	67	81	N/A
12/31/2022	569	1	70	77	N/A
9/30/2022	528	-29	20	56	N/A
6/30/2022	482	-37	5	49	N/A
3/31/2022	403	-45	-19	34	N/A
12/31/2021	302	-44	-30	22	N/A
9/30/2021	204	-29	-13	10	N/A
6/30/2021	117	-21	-10	2	N/A
3/31/2021	66	-9	-4	-4	N/A
12/31/2020	50	-4	-7	-5	N/A
9/30/2020	43	-9	-5	-4	N/A
6/30/2020	39	-10	-4	-3	N/A
3/31/2020	36	-8	-4	-3	N/A
12/31/2019	33	-8	-3	-3	N/A
12/31/2018	9	-2	N/A	-1	N/A
10/31/2018	6	-2	N/A	-1	N/A
7/31/2018	4	-6	N/A	-1	N/A
4/30/2018	2	-6	N/A	-1	N/A
1/31/2018	0	-6	N/A	-1	N/A
10/31/2017	N/A	-1	N/A	-1	N/A
7/31/2017	0	-1	N/A	-1	N/A
3/31/2017	0	0	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
10/31/2016	0	-1	N/A	0	N/A
12/31/2015	0	-1	N/A	0	N/A

애널리스트 향후 성장 전망

수입 대 저축률: WELL 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(2.6%)보다 빠른 성장으로 간주됩니다.

수익 vs 시장: WELL (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: WELL 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: WELL 의 수익(연간 14.3%)이 Canadian 시장(연간 4.1%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: WELL 의 수익(연간 14.3%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: WELL의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.

성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2025/10/06 01:44
종가	2025/10/06 00:00
수익	2025/06/30
연간 수익	2024/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

WELL Health Technologies Corp.는 15명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
Gabriel Leung	Beacon Securities Limited
Douglas Taylor	Canaccord Genuity
Scott Fletcher	CIBC Capital Markets

WELL Health Technologies 향후 성장

Future 기준 점검 4/6

핵심 정보

최근 향후 성장 업데이트

WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Well Health Technologies Corp. Reaffirms Earnings Guidance for 2025

WELL Health Technologies Corp. Updates Earnings Guidance for 2025

Consensus EPS estimates fall by 27%, revenue upgraded

Price target decreased by 8.9% to CA$7.65

Consensus revenue estimates increase by 15%

Recent updates

Insufficient new directors

WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Second quarter 2025 earnings: EPS exceeds analyst expectations

Well Health Technologies Corp. Reaffirms Earnings Guidance for 2025

WELL Health Technologies Corp. to Report Q2, 2025 Results on Aug 14, 2025

WELL Health Technologies Corp. Updates Earnings Guidance for 2025

WELL Health Technologies Corp. (TSX:WELL) acquired Specialty clinic in Burnaby, BC.

WELL Health Technologies Corp. Announces Appointment of Ric Leong as Chief Accounting Officer, Effective May 20

First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 27%, revenue upgraded

WELL Health Technologies Corp. to Report Q1, 2025 Results on May 14, 2025

Price target decreased by 8.9% to CA$7.65

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Consensus revenue estimates increase by 15%

Full year 2024 earnings: EPS and revenues miss analyst expectations

WELL Health Technologies Corp. Provides Earnings Guidance for 2025

WELL Health Technologies Corp., Annual General Meeting, Jun 19, 2025

WELL Health Technologies Corp. to Report Q4, 2024 Results on Apr 14, 2025

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Investor sentiment deteriorates as stock falls 21%

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Microquest Inc

Independent Director exercised options and sold CA$198k worth of stock

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Price target increased by 8.9% to CA$8.37

Investor sentiment improves as stock rises 23%

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Chief Operating Officer exercised options to buy CA$1.6m worth of stock.

New major risk - Revenue and earnings growth

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Independent Director exercised options and sold CA$144k worth of stock

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

Consensus EPS estimates upgraded to CA$0.08 loss

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Independent Director recently sold CA$160k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.